Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of Los Angeles Times, shared a post on X:
“This is the complexity of the cancer cell fighting our immune system. Have been obsessed since the invention of Abraxane, which took 10 years to get approved, then onto NK cells with identified NK-92 in 1992, and then to IL15 in 2015. Slowly, we are outsmarting the cancer regardless of the tumor type.”
More posts featuring Pat Soon-Shiong.